Study Urges New Targets on Blood Pressure

via Wall Street Journal

In a finding that may upend conventional wisdom about treating hypertension, scientists with the National Institutes of Health said that aggressive reduction of blood pressure to levels under current targets can significantly reduce rates of cardiovascular disease and death in hypertension patients.

Using medication to lower systolic blood pressure to less than 120 reduced the risk of heart attack and stroke by almost a third, and death by almost a quarter, compared with lowering it to a commonly recommended target of less than 140, the National Heart, Lung, and Blood Institute said Friday.

The study’s results were so striking that the 9,300-person trial was stopped more than a year ahead of schedule in order to “quickly disseminate the significant preliminary results,” the NHLBI said.

To read the full article CLICK HERE

Advertisements

About thebenefitblog

Eric is a Producer at Lockton Insurance Brokers, Inc., the world’s largest privately held commercial broker. Eric has over 23 years of experience in the insurance industry and has spent the last 11 years with Lockton. Eric specializes in Health & Welfare Benefits, Retirement Planning, and Executive Benefits. Eric's clients utilize his expertise in the areas of Plan Due Diligence, Transaction Structure, Fiduciary Oversight, Investment Design, Compliance and Vendor negotiation to improve the operational & financial outcome for each client. The Benefit Blog is a place to share that expertise and industry news.
This entry was posted in Uncategorized. Bookmark the permalink.